CN101199652A - Medicament for treating acute, subacute eczema and preparing method thereof - Google Patents
Medicament for treating acute, subacute eczema and preparing method thereof Download PDFInfo
- Publication number
- CN101199652A CN101199652A CNA2006101368887A CN200610136888A CN101199652A CN 101199652 A CN101199652 A CN 101199652A CN A2006101368887 A CNA2006101368887 A CN A2006101368887A CN 200610136888 A CN200610136888 A CN 200610136888A CN 101199652 A CN101199652 A CN 101199652A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- acute
- medicine
- volatile oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 27
- 230000001154 acute effect Effects 0.000 title claims abstract description 17
- 208000010668 atopic eczema Diseases 0.000 title claims description 24
- 238000000034 method Methods 0.000 title abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 26
- 238000001035 drying Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000202807 Glycyrrhiza Species 0.000 claims abstract description 3
- 241000207929 Scutellaria Species 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 19
- 239000000341 volatile oil Substances 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 13
- 238000001556 precipitation Methods 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229940126678 chinese medicines Drugs 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 238000001256 steam distillation Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 238000004821 distillation Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 238000005057 refrigeration Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 238000010189 synthetic method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- -1 flavone compound Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 229960001660 histamine phosphate Drugs 0.000 description 2
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 231100000668 minimum lethal dose Toxicity 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- ZJQHXIIOVKOVID-RDBSUJKOSA-N Chrysanthetriol Chemical compound CC(C)(O)[C@@H]1CCC(=C)[C@@H](O)CCC(=C)[C@@H](O)C1 ZJQHXIIOVKOVID-RDBSUJKOSA-N 0.000 description 1
- ZJQHXIIOVKOVID-UHFFFAOYSA-N Chrysanthetriol Natural products CC(C)(O)C1CCC(=C)C(O)CCC(=C)C(O)C1 ZJQHXIIOVKOVID-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 206010037218 Psychopathic personality Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 206010046750 Urticaria papular Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 208000008664 papular urticaria Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- DSNIKOZTDZBWKD-XMNJDQQWSA-N yejuhua lactone Chemical compound O([C@H]1C2C[C@H]([C@@](C3C1C(=CC3)C)(C)O)OC(=O)C)C(=O)C2(C1(C)C=C2)CC22C1[C@H]1OC(=O)C(=C)C1CC[C@@]2(C)O DSNIKOZTDZBWKD-XMNJDQQWSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101368887A CN101199652B (en) | 2006-12-15 | 2006-12-15 | Medicament for treating acute, subacute eczema and preparing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101368887A CN101199652B (en) | 2006-12-15 | 2006-12-15 | Medicament for treating acute, subacute eczema and preparing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101199652A true CN101199652A (en) | 2008-06-18 |
CN101199652B CN101199652B (en) | 2010-07-14 |
Family
ID=39515134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101368887A Active CN101199652B (en) | 2006-12-15 | 2006-12-15 | Medicament for treating acute, subacute eczema and preparing method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101199652B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127322A (en) * | 2011-11-29 | 2013-06-05 | 王莲芬 | Traditional Chinese medicine composition for curing subacute eczema |
CN103202981A (en) * | 2013-05-08 | 2013-07-17 | 山东新希望六和集团有限公司 | Medicine for treating trauma infectious diseases of animals |
CN104784293A (en) * | 2015-03-30 | 2015-07-22 | 郭光艳 | Traditional Chinese medicine composition for treating extensive heat type subacute eczema |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100496555C (en) * | 2005-09-22 | 2009-06-10 | 华玉强 | Detoxification and itching-relieving medicine composition and preparing method |
CN1857573A (en) * | 2006-03-24 | 2006-11-08 | 南凤龙 | Medicine for treating skin diseases |
-
2006
- 2006-12-15 CN CN2006101368887A patent/CN101199652B/en active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127322A (en) * | 2011-11-29 | 2013-06-05 | 王莲芬 | Traditional Chinese medicine composition for curing subacute eczema |
CN103202981A (en) * | 2013-05-08 | 2013-07-17 | 山东新希望六和集团有限公司 | Medicine for treating trauma infectious diseases of animals |
CN103202981B (en) * | 2013-05-08 | 2015-07-01 | 山东新希望六和集团有限公司 | Medicine for treating trauma infectious diseases of animals |
CN104784293A (en) * | 2015-03-30 | 2015-07-22 | 郭光艳 | Traditional Chinese medicine composition for treating extensive heat type subacute eczema |
Also Published As
Publication number | Publication date |
---|---|
CN101199652B (en) | 2010-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103585433B (en) | Traditional Chinese medicine composition for treating oral ulcer | |
CN103948786B (en) | Traditional Chinese medicine for treating diabetes | |
CN101239112A (en) | Chinese medicinal composition for regulating blood fat and preparation thereof | |
CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
CN101502588B (en) | Composition for beauty treatment and removing blain and method for preparing the same | |
CN101695327B (en) | Health-care kidney tea | |
CN107998313A (en) | A kind of Chinese medicine ferment for treating goat and preparation method thereof | |
CN101199652B (en) | Medicament for treating acute, subacute eczema and preparing method thereof | |
CN101961366A (en) | Preparation method of malan straw extract, malan straw product, pharmaceutical composition and application thereof | |
CN1939427B (en) | Prickly polygonum extract, its preparation, medicinal composition and use | |
CN102429961B (en) | Medicinal composition capsules for treating cold and preparation method thereof | |
CN103735695A (en) | Chinese medicine composition for treating urinary tract infection and preparation method thereof | |
CN101297857B (en) | Chinese medicine preparation for treating recessive mastitis of cow and preparation method thereof | |
CN103860977B (en) | A kind of pharmaceutical composition for the treatment of dermatitis | |
CN103735682B (en) | A kind of medicine that is used for the treatment of allergic dermatitis and preparation method thereof | |
CN103520684B (en) | Traditional Chinese medicine compound for reducing blood sugar | |
CN102755519B (en) | Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof | |
CN104587175B (en) | A kind of Chinese medicine preparation for treating diabetes | |
CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
CN104958474A (en) | Traditional Chinese medicine for treating damp heat stagnation type pancreatic cancer and preparation method thereof | |
CN105327147A (en) | Medicine composition for treating swine enzootic pneumonia and preparation method thereof | |
CN1327874C (en) | Chinese medicine formulation for treating chronic prostatitis and its preparing method | |
CN104173474A (en) | Traditional Chinese medicinal composition for improving reproductive function of sows, and preparation method thereof | |
CN104474430A (en) | Traditional Chinese medicine for treating liver-kidney yin deficiency type mycotic vaginitis and preparation method | |
CN104825955A (en) | Medicine composition used for treating constipation of cattle and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGXI JIMINKEXIN JINSHUIBAO PHARMACEUTICAL CO., Free format text: FORMER OWNER: LI YIHAI Effective date: 20090424 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090424 Address after: No. seven, No. 888, hi tech Zone, Nanchang hi tech Zone, Jiangxi Applicant after: Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Co., Ltd. Address before: No. seven, No. 888, hi tech Zone, Nanchang hi tech Zone, Jiangxi Applicant before: Li Yihai |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 330029 NO.888, GAOXIN ROAD 7, HIGH-TECH. ZONE, NANCHANG CITY, JIANGXI PROVINCE TO: 336000 NO.127, GAOSHI ROAD, YICHUN CITY, JIANGXI PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100518 Address after: 336000 Jiangxi city of Yichun province gaoshilu No. 127 Applicant after: Jiangxi Jimin Kexin Medicine Co., Ltd. Address before: 330029 No. seven, No. 888, hi tech Zone, Nanchang hi tech Zone, Jiangxi Applicant before: Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 336000 NO. 127, GAOSHI ROAD, YICHUN CITY, JIANGXI PROVINCE TO: 33600 MEDICINE INDUSTRIAL PARK, YUANZHOU DISTRICT, YICHUN CITY, JIANGXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110725 Address after: Thirty-three thousand and six hundred Pharmaceutical industry park, Yuanzhou District, Yichun, Jiangxi Patentee after: Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Address before: 336000 Jiangxi city of Yichun province gaoshilu No. 127 Patentee before: Jiangxi Jimin Kexin Medicine Co., Ltd. |